FDA Import Refusal 799-0345423-2/10002/1 — Novo Nordisk A/S
The FDA refused shipment 799-0345423-2/10002/1 from Novo Nordisk A/S (Denmark) on December 1, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 1, 2025
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 61PDC72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75